)
)
Panel Discussion: Can We Move From Silos to Systems to Scale Biodata for a Borderless Future?
-
How do we scale specific datasets (e.g. cancer genomics, rare disease) to unlock actionable insights?
-
What lessons can we learn from the UK's largest health datasets, like UK Biobank, Genomics England, and NHS EHR systems, in building scalable infrastructure and public trust?
-
How do we move from siloed to shared? Can we responsibly amalgamate data across institutions, geographies, and disease areas?
-
Is there a shared, global vision to make biodata truly interoperable and impactful, from prevention to precision care?
